To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century-Reference-Cited by-同舟云学术

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

Published:2013-05-06 Issue:12 Volume:48 Page:1497-1505
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ustun C,Lazarus H M,Weisdorf D

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201367.pdf

Reference75 articles.

1. Klepin HD, Balducci L . Acute myelogenous leukemia in older adults. Oncologist 2009; 14: 222–232.

2. Bureau USC 2010 Census shows 65 and older population growing faster than total U.S. population. http://www.census.gov/newsroom/releases/archives/2010_census/cb11-cn192.html .

3. Oran B, Weisdorf DJ . Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica 2012; 97: 1916–1924.

4. Juliusson G . Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry. Clin Lymphoma Myeloma Leuk 2011; 11 (Suppl 1): S54–S59.

5. Oshima K, Takahashi W, Asano-Mori Y, Izutsu K, Takahashi T, Arai Y et al. Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-Hocs). Ann Hematol 2012; 91: 1533–1539.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-08-30

2. Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?;Leukemia & Lymphoma;2024-07-23

3. Evaluating targeted therapies in older patients with TP53 -mutated AML;Leukemia & Lymphoma;2024-04-22

4. Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001;British Journal of Haematology;2023-11-12

5. Role of Measurable Residual Disease in Older Adult Acute Myeloid Leukemia;Clinical Interventions in Aging;2023-06